Brain-derived neurotrophic factor (BDNF) expression in hippocampus and
cortex is considerably reduced in Alzheimer's disease. The present st
udy tested if lysosomal disturbances, a concomitant of brain aging, im
pair basal and/or induced expression of BDNF. Cultured hippocampal sli
ces were incubated with N-CBZ-L-phenylalanyl-L-alanine-diazomethylketo
ne (ZPAD), an inhibitor of cathepsins B and L, for 6 days and processe
d for in situ hybridization using radiolabeled cRNA probes against BDN
F mRNA. Multiple densitometric readings were collected from each of th
e three principal hippocampal subdivisions. Within-slice averages were
substantially lower in the ZPAD-treated group compared to controls. T
reatment with the inhibitor did not change average neuron diameter or
packing density. Intense stimulation of glutamate receptors with kaina
te for 30 min (followed by a 90-min recovery period) caused a nearly t
hreefold increase in BDNF mRNA concentrations in the dentate gyrus whi
le having only marginal effects in the other subdivisions. Slice avera
ges of ZPAD-exposed cultures treated with kainate were lower than thos
e of controls exposed to the excitotoxin; however, on a percentage bas
is, the kainate-induced increase in the dentate gyrus was comparable f
or the two groups (175 +/- 31 vs 179 +/- 39%). Kainate for 1 h (with a
5-h recovery) affected BDNF mRNA in a manner similar to that found wi
th shorter infusions, i.e., induction in stratum granulosum but not el
sewhere, lower overall slice averages with ZPAD treatment, and no evid
ence that ZPAD blocked the percentage increase in the dentate gyrus. T
hese results provide evidence that lysosomal dysfunction occurring dur
ing brain aging could disrupt ongoing BDNF production without substant
ially impairing the neurotrophin response to intense physiological act
ivity. The first observation suggests a plausible aging sequence leadi
ng to pathology while the second may be of interest with regard to pos
sible therapeutics. (C) 1998 Academic Press.